// App-Quantinova.ai

BSH19‐EP‐052 : Life‐threatening Hypereosinophilic Syndrome in a 7 year old child

Researchers

Presenter

  • Y.L.T. Chan

Principal Investigators

  • J. Loke

  • J. Patel

  • J. Motwani

  • C. Horgan

Medical Centers

  • Department of Haematology, Birmingham Childrens Hospital, Birmingham, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

  • Pulmonary/Respiratory Diseases

  • Autoimmune (AI)

  • Blood/haematological Diseases

  • Infectious Diseases (ID)

  • Genetic Disorder

Disease

  • Hypereosinophilic Syndrome

  • Eosinophilic granulomatosis with polyangiitis

  • Dyspnea

  • Congestive heart failure

  • Viral myocarditis

  • Venous thrombosis

  • Asthma

Biomarkers

  • C reactive protein

  • Immunoglobulin E

Drug/Treatment

  • Methylprednisolone

  • Cyclophosphamide

  • Cyclophosphamide Injection

  • Hydroxycarbamide

  • Prednisolone

  • Mepolizumab

  • Cytarabine liposomal

  • Milrinone

  • Rituximab

  • Imatinib

  • IkT001

  • Heparin

  • Neut

Outcome

  • N/A

Study Design

  • Controlled

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved